Answers are grounded in this paper and cite their sources.
The percentage of human CD56−CD16+ NK cells increases during chronic infection with human HIV; however, the biologic role of CD56−CD16+ NK cells in HIV infection is unclear. Our results demonstrate that the percentage of CD56−CD16+ NK cells producing IL-10 and TGF-β was higher than CD56dimCD16+ NK cells. CD56−CD16+ NK cells could inhibit IFN-γ production by autologous CD8+ T cells, and this inhibition could be partially reversed by anti-IL-10, anti-TGF-β, or anti-PD-L1 mAbs. CD56−CD16+ NK cells are potential targets for the development of novel immune therapies against HIV infection.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: